Table 1. Baseline demographics and characteristics of the patients.
| Characteristic | Values* |
| Age (years) | 65.8±9.3 |
| Body weight (kg) | 57.9±9.8 |
| BMI (kg/m2) | 21.4±2.6 |
| Sex male/female** | 9/1 |
| Duration of diabetes (years) | 20.1±9.0 |
| HbA1c (%) | 5.9±0.9 |
| GA (%) | 21.0±2.8 |
| Creatinine (mg/dL) | 11.4±2.5 |
| BUN (mg/dL) | 62.4±16.9 |
| eGFR (mg/min/1.73 m2) | 4.2±1.3 |
| Total cholesterol (mg/dL) | 152.7±38.7 |
| Triglyceride (mg/dL) | 125.5±68.8 |
| AST (U/L) | 11.2±4.5 |
| ALT (U/L) | 10.2±6.0 |
| CPK (IU/L) | 74.6±30.5 |
| Uric acid (mg/dL) | 7.5±0.9 |
| Pre-treatment history | |
| Liraglutide only (n) | 9 |
| Insulin and liraglutide*** (n) | 1 |
*Values are mean ± SD (n = 10).
**0.9 mg (8 males and 1 female), 0.6 mg (1 male).
***1 patient had previously been treated with insulin only, and had switched to liraglutide 3 months prior to initiation of the study.
AST: Aspartate aminotransferase (SGOT).
ALT: Alanine aminotransferase (SGPT).
BUN: Blood urea nitrogen.
CPK: Creatinine phosphokinase.